reports
RavenQuest Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2020) - RavenQuest BioMed Inc. (CSE: RQB) (OTCQB: RVVQF) (FSE: 1IT) (the "Company" or "RavenQuest"), is pleased to provide the following update on all aspects of the Company's business plans for 2020 and beyond.RavenQuest has spent the last few months extensively reviewing the cannabis industry in Canada and internationally. The following are our key objectives near term:The Company's focus will be a technology company that grows cannabis using our technologies. This means we will be focusing on and growing our Consulting and Technolo...
RavenQuest BioMed Names New Legal Counsel and Auditors
RavenQuest BioMed Names New Legal Counsel and Auditors VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that, as part of the ongoing evolution of its corporate strategy, it has retained Farris LLP as its legal counsel and Dale Matheson Carr-Hilton Labonte LLP as its auditors. RavenQuest CEO, George Robinson, stated, “from a cannabis perspective, both Farris LLP and Dale Matheson Carr-Hilton Labonte LLP bring the experience, perspective and expertise we are looking ...
RavenQuest Files Response to Statement of Claim and Counter Claim
RavenQuest Files Response to Statement of Claim and Counter Claim VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”). On November 6, 2019 the Company announced that it and others have been sued in the Federal Court of Canada for alleged patent infringement of a stackable modular orbital gardening patent recently issued to Roto-Gro Inc. (). Today the Company announced that it has served Roto-Gro Inc. with its Statement of Defence and Counterclaim and that the pleading has been filed ...
RavenQuest Announces Change to Board of Directors
RavenQuest Announces Change to Board of Directors VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that Cassidy McCord has been appointed director of the Company. Ms. McCord’s bio can be found below. RavenQuest further announces the resignation from the board of Mark Ahrens-Townsend. “As RavenQuest evolves toward profitability, the composition of our board has taken shape to reflect our plans for 2020 and beyond," said George Robinson, RavenQuest CEO. "To fully re...
RavenQuest Announces Changes to Board of Directors
RavenQuest Announces Changes to Board of Directors VANCOUVER, British Columbia, Nov. 27, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that Usama Chaudhry and Jatinder Dhaliwal have been appointed directors of the Company. Mr. Chaudhry has also been appointed as interim CFO for the Company. Full bios for each gentleman can be found below. RavenQuest further announces the resignations from the board of Anton Drescher, Hendrik van Alphen and David Cross, CFO. “As our Company continues to evolve, we...
RavenQuest Completes First Cannabis Shipment to Australia
RavenQuest Completes First Cannabis Shipment to Australia VANCOUVER, British Columbia, Nov. 12, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis companies, announces it has successfully completed its first shipment of medical cannabis to Australia. RavenQuest cannabis was shipped to Medcan Australia (“Medcan”), a federally licensed Australian medical cannabis provider. “On November 8, 2019, Medcan took delivery of a nominal supply of cannabis which originated from RavenQuest’s...
RavenQuest Announces Key Changes to Its Board of Directors
RavenQuest Announces Key Changes to Its Board of Directors VANCOUVER, British Columbia, Nov. 01, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis companies, announces that Mark Percival and Mark Ahrens-Townsend have been elected as directors of the Company at its annual general meeting held on October 30, 2019. Further information on each can be found below. Messrs. Percival and Ahrens-Townsend fill the vacancies created by Chris Bechtel and Dr. Jorge Bonet, who did not stand ...
REPEAT – Ravenquest Client Achieves Landmark Success: Bonify Sales L...
REPEAT – Ravenquest Client Achieves Landmark Success: Bonify Sales License Fully Reinstated by Health Canada VANCOUVER, British Columbia, Oct. 24, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, announces that, for the first time in the history of Canadian legal cannabis sales, its client, Bonify, has had its Health Canada license suspension lifted and sales license fully reinstated. Following suspension of Bonify’s sales license in February 2019, RavenQuest’s servi...
Ravenquest Client Achieves Landmark Success: Bonify Sales License Full...
Ravenquest Client Achieves Landmark Success: Bonify Sales License Fully Reinstated by Health Canada VANCOUVER, British Columbia, Oct. 23, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, announces that, for the first time in the history of Canadian legal cannabis sales, its client, Bonify, has had its Health Canada license suspension lifted and sales license fully reinstated. Following suspension of Bonify’s sales license in February 2019, RavenQuest’s services team ...
RavenQuest Receives Health Canada Permit for Export to Australia
RavenQuest Receives Health Canada Permit for Export to Australia VANCOUVER, British Columbia, Oct. 08, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, announces that it has received a permit from Health Canada to allow the Company to export cannabis to Australia. The permit allows for the export of dried cannabis flower from the Company to Medcan Australia (“Medcan”), a federally licensed Australian medical cannabis provider. Shipments from RavenQuest to Medcan are...
RavenQuest BioMed to Hold Third Quarter Conference Call
RavenQuest BioMed to Hold Third Quarter Conference Call VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, announces it will hold a shareholder conference call on Wednesday, October 2 at 4:15pm ET / 1:15pm PT. RavenQuest CEO, George Robinson, will provide a company update, review recently released third quarter financials, and field questions from shareholders. Interested participants should follow the link below to register f...
RavenQuest Partner McGill University Secures Cannabis License
RavenQuest Partner McGill University Secures Cannabis License VANCOUVER, British Columbia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, is pleased to announce that its research partner, McGill University, has received a license from Health Canada which allows for the possession and production of cannabis for research purposes. The license allows RavenQuest and McGill to continue important research around the cannabis plant. The research continues to ...
RavenQuest Enters Cannabis Beverage Joint Venture With the Not-So-Gent...
RavenQuest Enters Cannabis Beverage Joint Venture With the Not-So-Gentle Tea Company VANCOUVER, British Columbia, Sept. 16, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, is pleased to announce it has signed a joint venture agreement with the Not-So-Gentle Tea Company (“NSGT”) to develop, market and sell teas and similar products infused with THC and CBD in Canada. “We are very excited to be working with the Not-So-Gentle Tea Company,” stated George Robinson, CEO o...
RavenQuest Signs European Joint Venture With Cannabis Biocare
RavenQuest Signs European Joint Venture With Cannabis Biocare VANCOUVER, British Columbia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, is pleased to announce it has signed a Joint Venture Agreement with Cannabis Biocare to construct cannabis cultivation facilities with planned capacity to produce 35,000 kilograms of medical cannabis in Europe. The Joint Venture plans to initially build two cannabis cultivation facilities in Portugal, with an option f...
RavenQuest Provides Shareholder Update
RavenQuest Provides Shareholder Update VANCOUVER, British Columbia, Aug. 07, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT), one of Canada’s most innovative cannabis companies, provides the following update on recent developments. Product Testing After the inaugural harvest at our Edmonton facility, Orbital Gardens have now successfully produced six cultivars including Brooklyn Sunrise, The Ultimate, CBD Compassion, CBD Kush, Charlottes Angel and CBD Skunk Haze. All of these cultivars passed analytical tests oth...
RavenQuest Provides Corporate Update
RavenQuest Provides Corporate Update VANCOUVER, British Columbia, June 26, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) is pleased to provide the following full update on all aspects of the Company’s production, distribution and expansion plans for 2019 and beyond. RavenQuest is gearing up for rapid growth in Canada as well as in Europe. Canadian production will accelerate to full capacity by summer 2019 and our European expansion is swiftly taking shape. We anticipate profitable operations in the near term,...
RavenQuest BioMed Expands Into Europe
RavenQuest BioMed Expands Into Europe VANCOUVER, British Columbia, May 22, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT1) (the “Company” or “RavenQuest”) is pleased to announce that it has signed a Heads of Agreement (the “HoA”) with Norway's Cannabis Biocare A/S (“Cannabis Biocare”) to enter into a joint venture (“JV”) to construct cannabis production facilities using RavenQuest's Orbital Garden grow technology in certain geographic regions. It is anticipated that production facilities will be constructed within twenty-four months, with the capac...
RavenQuest Awarded its First Cannabis Sales License from Health Canada
RavenQuest Awarded its First Cannabis Sales License from Health Canada VANCOUVER, British Columbia, May 06, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”) a federally-licensed producer of cannabis, is pleased to announce it has secured a Health Canada sales license at the Company’s Markham facility, also known as “Bloomera Inc.” The license allows RavenQuest to commence sales of both medical and recreational cannabis nationwide. Importantly, the license allows RavenQuest to route production from both its Markham and ...
RavenQuest Awarded its First Cannabis Sales License from Health Canada
RavenQuest Awarded its First Cannabis Sales License from Health Canada VANCOUVER, British Columbia, May 03, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”) a federally-licensed producer of cannabis, is pleased to announce it has secured a Health Canada sales license at the Company’s Markham facility, also known as “Bloomera Inc.” The license allows RavenQuest to commence sales of both medical and recreational cannabis nationwide. Importantly, the license allows RavenQuest to route production from both its Markham and ...
RavenQuest Completes First Cannabis Shipment to Wayland Group
RavenQuest Completes First Cannabis Shipment to Wayland Group VANCOUVER, British Columbia, April 15, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”) a federally licensed producer of cannabis, is pleased to announce it has completed its first shipment of bulk cannabis to Wayland Group. The shipment was made as part of a larger agreement between RavenQuest and Wayland group, whereby RavenQuest will supply up to 8,000 kg of bulk cannabis to Wayland Group. The agreement spans the entirety of calendar 2019. ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.